*ST长药：因涉嫌定期报告等财务数据虚假记载被立案

Core Viewpoint - The company, *ST Changyao, has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation into alleged false financial reporting, which could lead to significant legal consequences and potential delisting of its stock [1] Group 1 - The company received the "Notice of Investigation" from the CSRC on November 7, 2025 [1] - The investigation is due to allegations of false records in periodic financial reports [1] - If the investigation confirms major violations, the company may face mandatory delisting due to serious legal infractions [1]